节点文献

卡铂、顺铂合用治疗肺癌的临床观察

Clinical observation of treatmeat of lung cancerwith cisplatin plus carboplatin

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 付建伟夏晋

【Author】 FU Jian wei,XIA JingChong Qing Emergency and Medical Centre,ChongQing 400014

【机构】 重庆市急救中心肿瘤科!重庆400014

【摘要】 目的 :卡铂、顺铂合用治疗肺癌临床疗效观察。方法 :122例Ⅲ~Ⅳ期肺癌病人随机分为三组 ,行联合化疗 ,每4周重复一疗程。结果 :DDP +VP1640例 ,CR +PR18例 ,有效率45.00 % ,Ⅱ度以上呕吐发生率87.50% ,Ⅱ度以上白细胞下降率37.50% ;CBP +VP1640例 ,有效率45.00% ,Ⅱ度以上白细胞下降率90.00% ;1/2DDP+1/2CBP +VP1642例 ,CR +PR16例 ,有效率38.13% ,Ⅱ度以上呕吐发生率47.62% ,Ⅱ度以上白细胞下降率42.85%。结论 :卡铂、顺铂合用 ,剂量减半可以不影响疗效 ,但能明显减少毒性反应。

【Abstract】 Objective:To investigate the therapeutic effect of cisplatin plus carboplatin in lung cancer treatment.Method:122 cases of advanced lung cancer were randomly divided into three groups.Patients of each group were treated with carboplatin or cisplatin or both plus etoposide respectivly.Rsults:For the 40 cases of cisplatin plus etoposide(vp 16),the CR+PR rate was 45.00%,vomiting over grade Ⅱ 87.50%,leukopenia over grade Ⅱ 37.50%;for 40 cases of carboplatin plus etoposide,the CR+PR rate was 45.00%,leukopenia over grade Ⅱ 90%;for the 42 cases of half dosage cisplatin and the half dosage carboplatin plus etoposide,the CR+PR rate was 38.13%,vomiting over grade Ⅱ 47.62%,leukopenia over grade Ⅱ 42.85%.Conclusion:The half dosage of cisplatin plus carboplatin has no influence on therapeutic effects,but will reduce toxic reaction (vomiting and leukopenia).

【关键词】 肺癌卡铂顺铂
【Key words】 Lung cancerCisplatinCarboplatin
  • 【文献出处】 四川肿瘤防治 ,SICHUAN JOURNAL OF CANCER CONTROL , 编辑部邮箱 ,2000年02期
  • 【分类号】R734.2
  • 【被引频次】2
  • 【下载频次】39
节点文献中: 

本文链接的文献网络图示:

本文的引文网络